Brian Jonas

Brian Jonas

University of California Davis - Davis / United States
Others
AD Scientific Index ID: 1747490
person_outline Brian Jonas's MOST POPULAR ARTICLES
1-) Azacitidine and venetoclax in previously untreated acute myeloid leukemiaCD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ...New England Journal of Medicine 383 (7), 617-629, 202015092020
2-) Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemiaCD DiNardo, K Pratz, V Pullarkat, BA Jonas, M Arellano, PS Becker, ...Blood, The Journal of the American Society of Hematology 133 (1), 7-17, 201915022019
3-) Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label …CD DiNardo, KW Pratz, A Letai, BA Jonas, AH Wei, M Thirman, ...The lancet oncology 19 (2), 216-228, 20185322018
4-) Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trialJE Cortes, S Khaled, G Martinelli, AE Perl, S Ganguly, N Russell, ...The Lancet Oncology 20 (7), 984-997, 20194952019
5-) How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemiaBA Jonas, DA PollyeaLeukemia 33 (12), 2795-2804, 20191842019